Trials / Sponsors / Faraday Pharmaceuticals, Inc.
Faraday Pharmaceuticals, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Evaluation in STEMI Patients Using FDY-5301 Acute Myocardial Infarction, STEMI, Percutaneous Coronary Revascularization | Phase 3 | 2022-05-02 |
| Terminated | Evaluation of FDY-5301 in Major Trauma Patients in ICU ICU Acquired Weakness | Phase 2 | 2021-09-20 |
| Completed | A Study of Acute Myocardial Infarction Using FDY-5301 Acute Myocardial Infarction, STEMI | Phase 2 | 2017-10-27 |